Chorionic villus sampling and amniocentesis in 2008

Current Opinion in Obstetrics and Gynecology

Volumn 20, Issue 2, 2008, Pages 164-168

  Evans, Mark I ^a,b,c   Andriole, Stephanie ^a,b  

^a Fetal Medicine Foundation of America   (United States)

^b Comprehensive Genetics ^*  (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Amniocentesis; Chorionic villus sampling; Prenatal diagnosis

Indexed keywords

AMNIOCENTESIS; CHORION VILLUS SAMPLING; COHORT ANALYSIS; HISTORY; LEARNING; MEDICAL LITERATURE; METHODOLOGY; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; REVIEW; RISK;

AMNIOCENTESIS; CHORIONIC VILLI SAMPLING; FEMALE; HUMANS; PREGNANCY; PREGNANCY OUTCOME; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS;

EID: 41849144146     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/GCO.0b013e3282f7321f     Document Type: Review

References (36)

1. Jacobson CB, Barter RH. Intrauterine diagnosis and management of genetic defects. Am J Obstet Gynecol 1967; 99:795-798.
2. Nadler HL, Gerbie AB. Role of amniocentesis in the intrauterine detection of genetic disorders. N Engl J Med 1970; 282:596-693.
3. Evans MI. Reproductive risks and prenatal diagnosis. New York: McGraw Hill Publishing Co.; 1992.
4. Drugan A, Evans MI. Amniocentesis. In: Evans MI, Johnson MP, Yaron Y, Drugan A, editors. Prenatal diagnosis 2006. New York: McGraw Hill Publishing Co; 2006. pp. 415-422.
5. Tabor A, Philip J, Madsen M, et al. Randomised controlled trial of genetic amniocentesis in 4606 low-risk women. Lancet 1986; 1:1287-1293.
6. Evans MI, Bottoms SF, Critchfield GC, et al. Parental perception of genetic risk: Correlation with choice of prenatal diagnostic procedures. Int J Gynaecol Obstet 1990; 31:25-28.
7. Eisenberg B, Wapner RJ. Clinical procedures in prenatal diagnosis. In: Evans MI, Bui TH, editors. The genome revolution and obstetrics and gynecology. Balliere's best practice and research in clinical obstetrics and gynecology. London: Harcourt Brace Publishing Co.; 2002. p. 16.
8. Jackson LG, Zachary JM, Fowler SE, et al. A randomized comparison of transcervical and transabdominal chorionic-villus sampling. The U.S. National Institute of Child Health and Human Development Chorionic-Villus Sampling and Amniocentesis Study Group. N Engl J Med 1992; 327:594-598.
9. Rhoads GG, Jackson LG, Schlesselman SE, et al. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med 1989; 320:609-617.
10. Seeds JW. Diagnostic mid trimester amniocentesis: how safe? Am J Obstet Gynecol 2004; 191:607-615.
11. Dommergues M. Prenatal diagnosis for multiple pregnancies. Curr Opin Obstet Gynecol 2002; 14:169-175.
12. Eddleman KA, Malone FD, Sullivan L, et al. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 2006; 108:1067-1072. This controversial paper reports an extremely low complication rate following genetic amniocentesis.
13. Evans MI, Hanft RS. The introduction of new technologies. ACOG Clinical Seminars 1997; 2:1-3.
14. Cohen AB, Hanft RS. Technology in American Healthcare: Policy directions for effective evaluation and management. Ann Arbor: University of Michigan Press; 2004.
15. Evans MI, Rosner G, Yaron Y, et al. Chorionic villus sampling. In: Evans MI, Johnson MP, Yaron Y, Drugan A, editors. Prenatal diagnosis 2006. New York: McGraw Hill Publishing Co; 2006. pp. 433-442.
16. Evans MI, Drugan A, Koppitch FC, et al. Genetic diagnosis in the first trimester: The norm for the 90s. Am J Obstet Gynecol 1989; 160:1332-1339.
17. Firth HV, Boyd P, Chamberlain P, et al. Severe limb abnormalities after chorion villus sampling at 56-66 days' gestation. Lancet 1991; 337:726.
18. Burton BK, Schulz CJ, Burd LI. Limb anomalies associated with chorionic villus sampling. Obstet Gynecol 1992; 79:726-730.
19. Froster UG, Jackson L. Limb defects and chorionic villus sampling: results from an international registry, 1992-94. Lancet 1996; 347:489-494.
20. Kuliev A, Jackson L, Froster U, et al. Chorionic villus sampling safety. Report of World Health Organization/EURO meeting in association with the Seventh International Conference on Early Prenatal Diagnosis of Genetic Diseases, Tel-Aviv, Israel, May 21, 1994. Am J Obstet Gynecol 1996; 174:807-811.
21. Brambati B, Simoni G, Traui M. Genetic diagnosis by chorionic villus sampling before 8 gestational weeks: Efficiency, reliability, and risks on 317 completed pregnancies. Prenat Diagn 1992; 12:784-789.
22. Wapner RJ, Evans MI, Davis DO, et al. Procedural risks versus theology: chorionic villus sampling for orthodox Jews at less than 8 weeks' gestation. Am J Obstet Gynecol 2002; 186:1133-1136.
23. Nagel HTC, Vandenbussche FPHA, Keirse MJNC, et al. Amniocentesis before 14 completed weeks as an alternative to transabdominal chorionic villus sampling: A controlled trial with infant follow-up. Prenat Diagn 1998; 18:465-475.
24. Wilson RD. Early amniocentesis: A clinical review. Prenat Diagn 1995; 15:1259-1273.
25. The Canadian early and Mid-trimester Amniocentesis Trial (CEMAT) Group: Randomized trial to assess safety and fetal outcome of early and mid-trimester amniocentesis. Lancet 1998; 351:242-247.
26. Henry GP, Britt DW, Evans MI. Screening advances and diagnostic choice: the problem of residual risk. Fetal Diagn Ther (in press).
27. Wapner RJ, Thom E, Simpson JL, et al. First trimester maternal serum biochemistry and fetal nuchal translucency screening (BUN) study group: first trimester screening for trisomies 21 and 18. N Engl J Med 2003; 349:1405-1413.
28. Hyett J, Nicolaides KH. First trimester ultrasound screening with nuchal translucency. In: Evans MI, Johnson MP, Yaron Y, Drugan A, editors. Prenatal diagnosis 2006. New York: McGraw Hill Publishing Co; 2006. pp. 289-308.
29. Evans MI, Van Decruyes H, Nicolaides KH. Nuchal translucency (NT) measurements for 1st trimester screening: the "price" of inaccuracy. Fetal Diagn Ther 2007; 22:401-404.
30. Evans MI, Hallahan TW, Krantz D, Galen RS. Meta-analysis of first trimester Down Syndrome screening studies: Free beta hCG significantly outperforms intact hCG in a multimarker protocol. Am J Obstet Gynecol 2007; 196:198-205.
31. Caughey AB, Hopkins LM, Norton ME. Chorionic villus sampling compared with amniocentesis and the difference in the rate of pregnancy loss. Obstet Gynecol 2006; 108:612-616. The gap between risks of CVS and amniocentesis has narrowed to be insignificant in experienced hands.
32. Wapner RJ, Evans MI, Platt LD. Pregnancy loss rates after midtrimester amniocentesis [letter]. Obstet Gynecol 2007; 109:780.
33. Nicolaides KH. Pregnancy loss rates after midtrimester amniocentesis [letter]. Obstet Gynecol 2007; 109:780.
34. Alfirevic Z, Tabor A. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol 2007; 109:1203-1204.
35. Mujezinovic F, Alfirevic Z. Procedure related complications of amniocentesis and chorionic villus sampling. Obstet Gynecol 2007; 110:687-694. This meta-analysis showed that there is no difference in procedure risks between CVS and amniocentesis in experienced hands.
36. Evans MI, Wapner RJ. Invasive prenatal diagnostic procedures 2005. Semin Perinatol 2005; 29:215-218.